Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VA-BRAVE
NCT04375033Phase 4Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2020
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by VA Office of Research & Development. Started Nov 2020; status: recruiting.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04375033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375033.